NCT04857671View on ClinicalTrials.gov

Botulinum Toxin A in Frequent and Chronic Tension-type Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

December 4, 2024

Study Completion Date

December 4, 2024

Conditions
Tension-Type Headache
Interventions
DRUG

Botulinum Toxin Type A in saline water

"100 Allergan units Botulinum toxin A in a total of 2 ml sodium chloride (NaCl) 0,9% Braun.~5 IU of Botox per injection point (0,1ml); in total 100 IU per 20 injections points."

DRUG

Isotone saline water

2ml Na Cl (sodium chloride) 0,9% Braun. 0,1ml per injection point in total 20 injections points

Trial Locations (1)

Unknown

Namsos Sykehus, Namsos

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

collaborator

Sandvika Nevrosenter

UNKNOWN

lead

Helse Nord-Trøndelag HF

OTHER